Clinical Trial Update: AVENTINE-1: Study of AVZO-1418 as a Single Agent and in Combination Therapy in Patients With Locally Advanced or Metastatic Solid Tumors (AVZO-1418-1001) [Phase 1, Phase 2]

View source ↗

Summary

AVZO-1418 is being studied as a single agent and in combination therapy for locally advanced or metastatic solid tumors in a Phase 1/2 trial that is currently r…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer
• Carcinoma
• Lung Cancer
• Solid Tumors

Drugs mentioned

• AVZO-1418

Snippet

Sponsor: Avenzo Therapeutics, Inc. | Conditions: Solid Tumor Cancer, Locally Advanced | Phase 1, Phase 2 | Status: RECRUITING